| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fa9a2244bcefb810096034dd8bb5827 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-566 |
| filingDate |
2005-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f34fee6d9a1881f588f48b010903edbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07edea2fb203b15acc099fb909c72c0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54259e42dcd1b711fe35d91ece474299 |
| publicationDate |
2015-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2553101-T3 |
| titleOfInvention |
Precursor of sex steroids in combination with a selective estrogen receptor modulator for the prevention and treatment of vaginal atrophy in postmenopausal women |
| abstract |
Dehydroepiandrosterone in combination with a therapeutically effective amount of acolbifene as part of a combination therapy, for use in the treatment or in reducing the likelihood of acquiring a vaginal disease that affects the layer of the lamina propria, in which the Vaginal disease is atrophy of the lamina of the lamina propria in postmenopausal women. |
| priorityDate |
2004-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |